25 May 2022 | News
Focusing on development and capacity-building for global health
South Korea-based International Vaccine Institute (IVI) and Armauer Hansen Research Institute (AHRI), established by the Government of Ethiopia in collaboration with Save the Children Organizations of Norway and Sweden, held a ceremony recently to launch the AHRI-IVI Collaborating Center.
The AHRI-IVI Collaborating Center is a research and training site to advance vaccines for global health. Collaborators from both organizations will conduct vaccine research and clinical development, engage in disease surveillance and policy studies, provide training across vaccinology, and support vaccine introduction programs.
The AHRI-IVI Collaborating Center is the third of its kind, joining a network of IVI Collaborating Centers in Ghana and Madagascar with the aim of co-developing research projects and building in-country capacity.
On May 11, 2022, IVI and AHRI launched the first round of a mass vaccination campaign to provide 100,000 residents of Ethiopia with oral cholera vaccine (OCV). This vaccination campaign is part of the Ethiopia Cholera Control and Prevention (ECCP) project, supported by LG Electronics and Korea Support Committee to IVI, to protect people living in Ethiopia’s cholera-endemic hotspot areas. This joint project aims to contribute to the evidence-based public health policies in Ethiopia and work towards the ‘Ending Cholera – A Global Roadmap to 2030.’